UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice

Vaccine, 2024-11, Vol.42 (25), p.126213, Article 126213

2024

Volltextzugriff (PDF)

A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters

Vaccine, 2024-10, Vol.42 (24), p.126269, Article 126269

2024

Volltextzugriff (PDF)

The effect of recombinant zoster vaccine on patients with chronic obstructive pulmonary diseases: A multi‐institutional propensity score‐matched cohort study

Journal of medical virology, 2024-09, Vol.96 (9), p.e29911-n/a

2024

Volltextzugriff (PDF)

Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis

Scientific reports, 2024-09, Vol.14 (1), p.22631, Article 22631

2024

Volltextzugriff (PDF)

A second-generation recombinant BCG strain combines protection against murine tuberculosis with an enhanced safety profile in immunocompromised hosts

Vaccine, 2024-10, Vol.42 (24), p.126291, Article 126291

2024

Volltextzugriff (PDF)

Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine

Vaccine, 2024-09, Vol.42 (22), p.126205, Article 126205

2024

Volltextzugriff (PDF)

Cold‐adapted influenza‐vectored RSV vaccine protects BALB/c mice and cotton rats from RSV challenge

Journal of medical virology, 2024-07, Vol.96 (7), p.e29308-n/a

2024

Volltextzugriff (PDF)

A decavalent composite mRNA vaccine against both influenza and COVID-19

mBio, 2024-09, Vol.15 (9), p.e0066824

2024

Volltextzugriff (PDF)

Post-Hoc Analysis of Potential Correlates of Protection of a Recombinant SARS-CoV-2 Spike Protein Extracellular Domain Vaccine Formulated with Advax-CpG55.2-Adjuvant

International journal of molecular sciences, 2024-08, Vol.25 (17), p.9459

Petrovsky, Nikolai

2024

Volltextzugriff (PDF)

Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens

PloS one, 2024-07, Vol.19 (7), p.e0307100

2024

Volltextzugriff (PDF)

Immunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep

Anaerobe, 2024-10, Vol.89, p.102895, Article 102895

2024

Volltextzugriff (PDF)

Development of mRNA rabies vaccines

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2382499

2024

Volltextzugriff (PDF)

Editorial Note: Clinical and Parasitological Protection in a Leishmania infantum-Macaque Model Vaccinated with Adenovirus and the Recombinant A2 Antigen

PLoS neglected tropical diseases, 2024-09, Vol.18 (9), p.e0012499

2024

Volltextzugriff (PDF)

An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge

Antiviral research, 2024-10, Vol.230, p.105974, Article 105974

2024

Volltextzugriff (PDF)

Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques

Viruses, 2024-07, Vol.16 (8), p.1181

2024

Volltextzugriff (PDF)

Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2

Frontiers in immunology, 2024-07, Vol.15, p.1416375

2024

Volltextzugriff (PDF)

Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial

The Lancet global health, 2024-08, Vol.12 (8), p.e1288-e1299

2024

Volltextzugriff (PDF)

The Healthcare Study Examines the Humoral Anti-S1 Antibody Response Following mRNA Vaccination, Comparing Individuals with and without Prior SARS-CoV-2 Infection

Archivum Immunologiae et Therapiae Experimentalis, 2024-01, Vol.72 (1)

2024

Volltextzugriff (PDF)

Rational optimization of glycoprotein E (gE)-encoding mRNA for improved Varicella-zoster virus mRNA vaccine development

Emerging microbes & infections, 2024-12, Vol.13 (1), p.2392661

2024

Volltextzugriff (PDF)

mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses

Viruses, 2024-09, Vol.16 (9), p.1404

2024

Volltextzugriff (PDF)

Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2389602

2024

Volltextzugriff (PDF)

Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial

The Journal of infectious diseases, 2024-07, Vol.230 (1), p.e4

2024

Volltextzugriff (PDF)

Persistent longitudinal T cell responses after SARS-CoV-2 mRNA vaccines in MS patients on different disease modifying treatments

Multiple sclerosis and related disorders, 2024-10, Vol.90, p.105813, Article 105813

2024

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 90 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Vaccines, Synthetic - Immunology
(26)
Vaccines, Synthetic - Administration & Dosage
(25)
Female
(21)
Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Humans
(18)
Animals
(15)
Antibodies, Viral - Blood
(15)
Antibodies, Viral - Immunology
(14)
Vaccines
(13)
Covid-19 - Prevention & Control
(12)
Immunogenicity
(12)
Mrna Vaccines
(12)
Sars-Cov-2 - Immunology
(12)
Covid-19 - Immunology
(11)
Covid-19 Vaccines - Immunology
(11)
Immunology
(11)
Adult
(10)
Covid-19 Vaccines - Administration & Dosage
(10)
Immunogenicity, Vaccine
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice

Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial

A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters

The effect of recombinant zoster vaccine on patients with chronic obstructive pulmonary diseases: A multi‐institutional propensity score‐matched cohort study

Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis

A second-generation recombinant BCG strain combines protection against murine tuberculosis with an enhanced safety profile in immunocompromised hosts

Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine

Cold‐adapted influenza‐vectored RSV vaccine protects BALB/c mice and cotton rats from RSV challenge

A decavalent composite mRNA vaccine against both influenza and COVID-19

Post-Hoc Analysis of Potential Correlates of Protection of a Recombinant SARS-CoV-2 Spike Protein Extracellular Domain Vaccine Formulated with Advax-CpG55.2-Adjuvant

Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens

Immunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep

Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses

Development of mRNA rabies vaccines

Editorial Note: Clinical and Parasitological Protection in a Leishmania infantum-Macaque Model Vaccinated with Adenovirus and the Recombinant A2 Antigen

An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge

Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques

Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2

Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial

The Healthcare Study Examines the Humoral Anti-S1 Antibody Response Following mRNA Vaccination, Comparing Individuals with and without Prior SARS-CoV-2 Infection

Rational optimization of glycoprotein E (gE)-encoding mRNA for improved Varicella-zoster virus mRNA vaccine development

mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses

Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China

Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial

Persistent longitudinal T cell responses after SARS-CoV-2 mRNA vaccines in MS patients on different disease modifying treatments

Aktive Filter

Suchergebnisse filtern